The TMS Medicare Reimbursement Playbook 2026

Learn what drives Medicare reimbursement for TMS therapy, from documentation and CPT codes to prior authorization and denial prevention.

Blog

Key Takeaways

Medicare reimbursement for TMS hinges on documentation, not just correct coding.
Three CPT codes cover the treatment course: 90867 for initial mapping, 90868 for follow-up sessions, and 90869 for motor threshold redetermination when clinically needed.
Most denials come from operational gaps rather than clinical issues. Missing authorization, incomplete records, and coding errors are the biggest culprits.
Since Medicare Administrative Contractors set policy regionally, practices should stay current on their MAC’s specific guidance.

For psychiatric practices offering Transcranial Magnetic Stimulation (TMS), clinical outcomes and reimbursement performance are closely connected. A successful TMS program requires more than delivering treatment. It depends on accurate patient selection, consistent documentation, compliant billing workflows, and a clear understanding of Medicare coverage expectations.

Practice owners, clinicians, and administrators who understand these requirements are better positioned to reduce claim denials, improve operational efficiency, and maintain access to care for patients with treatment-resistant depression.

This playbook outlines the Medicare reimbursement considerations that matter most when delivering TMS in an outpatient psychiatric setting.

Where Medicare Fits Into TMS Care

Medicare Part B may cover TMS for eligible patients with major depressive disorder when medical necessity requirements are met. Coverage is generally tied to documented treatment resistance, appropriate clinical evaluation, and adherence to applicable Medicare coverage policies.

Because coverage implementation may vary by Medicare Administrative Contractor (MAC), practices should review the policies governing their geographic region before initiating treatment.

For many psychiatric practices, reimbursement success begins well before the first TMS session is delivered.

Documentation and Medical Necessity

Medicare reimbursement is ultimately tied to whether the patient’s medical record supports the need for treatment, both before the course begins and throughout it.

Before treatment starts, practices must establish a confirmed diagnosis of severe major depressive disorder and demonstrate that prior treatment approaches, including medication trials and psychotherapy, have not produced sufficient improvement. Documentation should describe medication names, dosages, treatment duration, patient response, and any adverse effects that affected continuation of therapy. The goal isn’t simply to show that medications were prescribed, but to demonstrate why TMS became the appropriate next step in the patient’s care plan.

Once treatment begins, documentation should consistently capture treatment parameters, patient tolerance, clinical observations, and physician oversight. Incomplete or inconsistent records at either stage can create challenges during claim review, appeals, and audits. A complete clinical narrative, built before treatment starts and maintained throughout, is frequently the strongest defense against denials.

The Core TMS Billing Codes

Three CPT codes form the foundation of Medicare billing for TMS services.

CPT 90867

CPT 90867 is reported for the initial treatment session and includes cortical mapping, motor threshold determination, treatment delivery, and management. This code is generally billed once at the beginning of a treatment course.

CPT 90868

CPT 90868 is used for subsequent treatment sessions following the initial mapping and threshold determination.

Because a typical course of TMS may extend across multiple weeks, this code often represents the majority of claims submitted during treatment.

CPT 90869

CPT 90869 is used when motor threshold redetermination is clinically necessary during treatment.

This code should not be used routinely. Documentation should clearly support the need for reassessment and adjustment.

Reimbursement Considerations for 2026

Medicare reimbursement amounts are established through the Physician Fee Schedule and may vary based on geographic location and site-of-service factors.

Practices should verify current reimbursement rates within their MAC jurisdiction and consider both facility and non-facility payment differences when projecting program revenue.

While reimbursement values can change annually, operational success depends less on fee schedules and more on accurate documentation, coding compliance, and effective revenue cycle management.

The Role of Rating Scales

Objective outcome measurement remains an important component of TMS documentation.

Validated depression rating scales such as PHQ-9, HAM-D, or BDI can help establish baseline severity and demonstrate clinical progress throughout treatment.

Many practices incorporate rating scale assessments at intake, midpoint, and treatment completion to support both clinical decision-making and reimbursement documentation.

Prior Authorization Planning

Medicare prior authorization requirements can vary by region and payer arrangement.

Practices that incorporate authorization workflows into patient intake processes often experience fewer scheduling delays and reimbursement disruptions.

A strong authorization submission typically includes:

Comprehensive medication history
Current depression severity measures
Psychiatrist evaluation notes
Clinical rationale for TMS
Planned treatment protocol

Beginning the authorization process before scheduling treatment can help create a smoother patient experience.

Preventing Common Denials

Many TMS denials stem from operational issues rather than clinical appropriateness.

Insufficient evidence of treatment resistance, missing authorization requirements, coding errors, and incomplete documentation are among the most common causes of reimbursement challenges.

Successful practices often implement internal review processes that verify eligibility, documentation completeness, and coding accuracy before claims are submitted.

Proactive quality control is typically less costly than post-denial appeals.

Managing Retreatment Requests

Some patients who respond well to TMS may later experience symptom recurrence.

When retreatment is requested, documentation should demonstrate both the response achieved during the prior course and the return of clinically significant symptoms.

Comparing historical and current rating scale results can help support the clinical rationale for additional treatment.

A well-documented treatment history may strengthen requests for retreatment authorization when coverage policies permit.

Operational Workflow and MAC Alignment

High-performing TMS programs are built on repeatable workflows and close attention to regional policy.

Successful organizations typically standardize procedures for eligibility verification, prior authorization management, clinical documentation, rating scale collection, claim submission, denial tracking, and performance reporting. Monitoring claim acceptance rates, denial trends, reimbursement timelines, and treatment outcomes on a regular basis helps leaders catch workflow issues before they affect revenue cycle performance or patient access.

Because Medicare policies are administered regionally, maintaining familiarity with your MAC’s guidance is part of that same discipline. Practices should regularly review local coverage policies, billing articles, and policy updates related to TMS to reduce uncertainty and support more consistent reimbursement outcomes.

Key Takeaways for Practice Leaders

Medicare reimbursement for TMS depends on far more than selecting the correct CPT code. Clinical documentation, patient eligibility, authorization management, coding accuracy, and operational discipline all influence financial performance.

Practices that build reimbursement requirements directly into their clinical workflows are often better positioned to reduce denials, support compliance, and deliver sustainable access to TMS therapy. For psychiatric organizations investing in TMS, reimbursement strategy should be viewed as a core component of program design rather than an administrative task that occurs after treatment has already begun.

See how Psychiatry-Cloud can support your TMS program